Having trouble accessing articles? Reset your cache.

Dysport regulatory update

Ipsen said Health Canada approved Dysport abobotulinumtoxinA to treat glabellar lines. Valeant's Medicis Aesthetics Canada division is expected

Read the full 180 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE